ATLAS / Macro Radar / Reporting / ANTX

AN2 Therapeutics, Inc. (ANTX) reporting calendar

AN2 Therapeutics, Inc. files periodic reports with the SEC as ANTX on Nasdaq. Atlas tracks 17 filed reports for this issuer, each linked to its original EDGAR accession.

Next window
22 Jul 2026 – 2 Sep 2026
Latest report
10-Q
Period ended
31 Mar 2026
Filed
11 May 2026
Reports on record
17

How this window is derived. Derived from this issuer's own filing history: 9 periods at a median 91-day cadence, filed a median 43 days after period end. The SEC does not publish forward reporting dates and Atlas does not estimate one.

Open ANTX market profile Latest filing on SEC EDGAR ↗ Pharmaceutical Preparations reporting datesAll Nasdaq reporting dates

Filed periodic reports

FormPeriod endedFiledLagSEC accession
10-Q31 Mar 202611 May 202641 days0001193125-26-216755
10-K31 Dec 202517 Mar 202676 days0001193125-26-110693
10-Q30 Sep 202512 Nov 202543 days0001193125-25-277673
10-Q30 Jun 202512 Aug 202543 days0000950170-25-107301
10-Q31 Mar 202513 May 202543 days0000950170-25-070358
10-K31 Dec 202425 Mar 202584 days0000950170-25-044366
10-Q30 Sep 202413 Nov 202444 days0000950170-24-126282
10-Q30 Jun 202413 Aug 202444 days0000950170-24-096243
10-Q31 Mar 202414 May 202444 days0000950170-24-059556
10-K31 Dec 202329 Mar 202489 days0000950170-24-038681
10-Q30 Sep 20239 Nov 202340 days0000950170-23-062081
10-Q30 Jun 202310 Aug 202341 days0000950170-23-041378
10-Q31 Mar 202311 May 202341 days0000950170-23-021291
10-K31 Dec 202229 Mar 202388 days0000950170-23-010627
10-Q30 Sep 20229 Nov 202240 days0000950170-22-023901
10-Q30 Jun 202211 Aug 202242 days0000950170-22-016900
10-Q31 Mar 202210 May 202240 days0000950170-22-008999

Source: SEC EDGAR company submissions for CIK 0001880438. Atlas publishes filed facts only. The SEC does not publish forward reporting dates, so no announced future date is claimed here.